2022 Vascular Discovery: From Genes to Medicine

摘要 动脉硬化、血栓形成、血管生物学(ATVB)和外周血管理事会 美国心脏协会(AHA)的疾病(PVD)组织了一年一度的春季会议“血管发现： 从基因到医学“，最近的一次(面对面)于2019年5月5日至7日在伊利诺伊州芝加哥举行。这个 会议取得了巨大的成功，注册人数达到885人。560篇摘要被提交给 ATVB 2019，远高于前几年提交的典型~400篇摘要。这些 令人鼓舞的统计数据为科学家们的广泛兴趣和承诺提供了有形的证据 在ATVB、PVD和血管医学主题领域的社区和对 这次会议的形式和气氛。基础科学家、翻译研究人员和临床医生，经验丰富 研究人员和早期职业科学家，很高兴参加这次AHA春季会议。下一个ATVB/PVD 会议定于2022年5月20日至22日在路易斯安那州新奥尔良的希尔顿酒店举行。和以前一样 在以前的申请中，这项提议特别要求对我们的青年调查员旅行奖提供支持。 知道早期研究人员是我们科学进步的未来，我们的一个主要重点是 一年一度的会议旨在鼓励年轻一代的调查人员积极参与ATVB 和AHA的PVD理事会。青年研究员旅行奖由NIH/NHLBI资助 15年。这些奖项是我们招募、留住和积极吸引年轻人战略的组成部分 动脉硬化、血栓、血管生物学和血管医学研究领域的研究人员 这对NIH-NHLBI和美国人口的健康具有重大意义。

ABSTRACT The Councils on Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) and Peripheral Vascular Disease (PVD) of the American Heart Association (AHA) hold an annual Spring Meeting “Vascular Discovery: From Genes to Medicine” the most recent of which (in-person) was held in Chicago, IL, May 5-7, 2019. The meeting was a resounding success with 885 registrants. Five hundred and sixty abstracts were submitted to ATVB 2019, well above the typical ~400 abstracts that had been submitted in earlier years. These encouraging statistics provide tangible evidence of the broad interest and commitment of the scientific community in the topic areas of ATVB, PVD and vascular medicine and the overwhelming enthusiasm for the format and atmosphere of this meeting. Basic scientists, translational researchers and clinicians, seasoned investigators and early career scientists, enjoy coming to this AHA Spring meeting. The next ATVB/PVD conference is scheduled to be held May 20-22, 2022 at the Hilton in New Orleans, Louisiana. As with previous applications, this proposal specifically requests support for our Young Investigator Travel Awards. Knowing that early stage investigators are the future of our scientific progress, a major emphasis of our annual conference is to encourage the active involvement of the younger cohort of investigators in the ATVB and PVD Councils of the AHA. Young Investigator Travel Awards have been supported by the NIH/NHLBI for 15 years. These awards are an integral part of our strategy to recruit, retain and actively engage young investigators in the fields of arteriosclerosis, thrombosis, vascular biology and vascular medicine research that are of major importance to the NIH-NHLBI and the health of the U.S. population.